Destiny Pharma plc’s £8 Million Fundraise

Osborne Clarke advised finnCap Ltd and Shore Capital Stockbrokers Limited.The transaction involved the conditional £7 million placing and subscription and up to £1m open offer for…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Giulia Di Palma

Author: Giulia Di Palma

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here